330 related articles for article (PubMed ID: 10083506)
21. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
[No Abstract] [Full Text] [Related]
22. Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.
Facundo C; Diaz JM; Guirado L; Duran F; Herreros MA; Diaz M; Sola R
Transplant Proc; 2002 Feb; 34(1):98. PubMed ID: 11959203
[No Abstract] [Full Text] [Related]
23. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
[No Abstract] [Full Text] [Related]
24. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Marcas LI; Manresa JM; Masramón J
Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449
[No Abstract] [Full Text] [Related]
25. A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study Group.
Wiesel M; Carl S
J Urol; 1998 Jan; 159(1):28-33. PubMed ID: 9400430
[TBL] [Abstract][Full Text] [Related]
26. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J
Transplant Proc; 1999; 31(1-2):276-7. PubMed ID: 10083106
[No Abstract] [Full Text] [Related]
27. A randomized trial comparing two corticosteroid regimens combined with mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.
Juarez FJ; Barrios Y; Cano L; Lopez E; Martinez J; Limones M; Adalid C; Soria N; Medina JL
Transplant Proc; 2006 Nov; 38(9):2866-8. PubMed ID: 17112851
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
[No Abstract] [Full Text] [Related]
29. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
[No Abstract] [Full Text] [Related]
30. Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors.
Sánchez-Fructuoso AI; Prats D; Marques M; Ridao N; Conesa J; García Mena M; Torrente J; Barrientos A
Transplant Proc; 2003 Aug; 35(5):1689-90. PubMed ID: 12962759
[TBL] [Abstract][Full Text] [Related]
31. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
[TBL] [Abstract][Full Text] [Related]
32. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.
Vanrenterghem Y; Lebranchu Y; Hené R; Oppenheimer F; Ekberg H
Transplantation; 2000 Nov; 70(9):1352-9. PubMed ID: 11087152
[TBL] [Abstract][Full Text] [Related]
33. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study.
Puig i Marí JM
Transplant Proc; 1999 Sep; 31(6):2256-8. PubMed ID: 10500566
[No Abstract] [Full Text] [Related]
34. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Weber M; Deng S; Arenas J; Aradhye S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
[No Abstract] [Full Text] [Related]
35. Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea.
Lee S; Shin M; Kim E; Kim JM; Moon J; Jung G; Choi G; Kwon C; Joh J; Lee S; Kim S
Transplant Proc; 2010 Apr; 42(3):793-6. PubMed ID: 20430174
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
François M; Büchler M; Halimi JM; Al-Najjar A; Valentin JF; Thibault G; Lebranchu Y
Transplant Proc; 2000 Dec; 32(8):2781-2. PubMed ID: 11134803
[No Abstract] [Full Text] [Related]
37. Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function.
Liu B; Lin ZB; Ming CS; Zhang WJ; Chen ZS; Sha B; Zeng FJ; Chen S
Transplant Proc; 2003 Feb; 35(1):87-8. PubMed ID: 12591319
[No Abstract] [Full Text] [Related]
38. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Fabrega AJ; Corwin CL; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
[No Abstract] [Full Text] [Related]
39. A one-center experience with a short course of mycophenolic acid.
Stephan A; Barbari A; Kamel G; Aoun S; Masri MA
Transplant Proc; 1999 Dec; 31(8):3289-90. PubMed ID: 10616479
[No Abstract] [Full Text] [Related]
40. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
